Publicly Traded Hospice Companies Poised for Deals
Hospice News
MAY 24, 2024
The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Case in point, VITAS Healthcare, a subsidiary of Chemed Corp.
Let's personalize your content